Drug Discovery | XPRT
Articles & Whitepapers
-
In the NFL `Afterlife` everything hurts
Not too long ago in the August 4th version of the San Jose Mercury News, reporter Elliott Almond caught up with NFL Hall-of-Fame quarterback Jim Plunkett to talk about life after football. His response made headlines. "My life sucks", said Plunkett, now 69. "It’s no fun being in this body right now. Everything hurts." The years of daily pain pulsating from the neck, back, knees, ...
-
Mutation-directed Neo-protein-protein Interactions in Cancer
Genetic mutations in cells are an important cause of cancer development, progression, and drug resistance. How to quickly and accurately translate massive tumor genomic information into safe and ...
News
-
Chrysalis BioTherapeutics Receives Additional Funding from the National Institutes of Health for COVID-19 Therapeutic Development
Chrysalis BioTherapeutics, Inc., a clinical-stage biotechnology company developing regenerative drugs that target vascular endothelial and progenitor cells, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part ...
Drug developed by Galveston scientist to be tested for COVID-19 use
Chrysalis BioTherapeutics Receives Funding from the National Institutes of Health for COVID-19 Therapeutic Development
New Startup Makes Developing Gene Therapies Faster and Easier
Kadimastem Granted a Patent in Israel for the Treatment of ALS
Equipment & Solutions
-
Showcase
Single-use Pump Tubing Assemblies
ReadyCircuit single-use jumper tube sets with Pumpsil tubing terminating with ReadyMate connectors. Recommended pump: Watson Marlow series 520. Port tubing and ReadyMate single-use connectors are preconfigured into ReadyCircuit to interconnect with a variety of ReadyCircuit process components. Jumper assemblies are supplied gamma-irradiated with a certificate of quality. Silicone pump tubing ...
